Skip to content

Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

Hepatitis C meds GS-7977, daclatasvir and asunaprevir look good in interferon-free combos

Fumitaka Suzuki presenting at the International Liver Congress 2012. Photo by Liz Highleyman / aidsmap.com

Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C

Depression associated with socioeconomic difficulties and poor virological outcomes in UK HIV patients

Financial incentives and motivational interviewing being used to improve adherence in young people

Half of women at east London HIV clinic have experienced intimate partner violence

No significant link between injectable contraceptives and HIV risk, but questions still remain

No more single-theme conferences: global HIV prevention conference planned

Douching does not seem to increase STI risk